2011
DOI: 10.1016/j.jval.2011.01.011
|View full text |Cite
|
Sign up to set email alerts
|

Abstract: Evidence-based health care decision making requires comparison of all relevant competing interventions. In the absence of randomized controlled trials involving a direct comparison of all treatments of interest, indirect treatment comparisons and network meta-analysis provide useful evidence for judiciously selecting the best treatment(s). Mixed treatment comparisons, a special case of network meta-analysis, combine direct evidence and indirect evidence for particular pairwise comparisons, thereby synthesizing… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
579
0
12

Year Published

2013
2013
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 613 publications
(592 citation statements)
references
References 53 publications
1
579
0
12
Order By: Relevance
“…12, 13 We followed the International Society for Pharmacoeconomics and Outcomes Research approach on interpreting network meta-analyses for health-care decision-making. 14, 15 We used Grading of Recommendations Assessment, Development and Evaluation (GRADE) to appraise quality of evidence. 16 …”
mentioning
confidence: 99%
“…12, 13 We followed the International Society for Pharmacoeconomics and Outcomes Research approach on interpreting network meta-analyses for health-care decision-making. 14, 15 We used Grading of Recommendations Assessment, Development and Evaluation (GRADE) to appraise quality of evidence. 16 …”
mentioning
confidence: 99%
“…5 NMA is a generalization of traditional pairwise meta-analysis that compares all pairs of treatments within a set of to NMA. 7 We implemented a random-effects model assuming common heterogeneity across all comparisons.…”
Section: Accepted M Manuscriptmentioning
confidence: 99%
“…Methods for multivariate meta-analysis are being developed for the joint analysis of multiple outcomes, 52-57 multiple follow-ups 58,59 and multiple treatments. [60][61][62][63][64][65][66][67] In particular, methods for the meta-analysis of regression models may be especially relevant. 68 This would require reporting of the covariance matrices of risk prediction models, which is not common practice.…”
Section: 51mentioning
confidence: 99%